Pure Global
NCT06357897

The Efficacy and Palatability of Developed Polyethylene Glycol-based Formula for Children With Functional Constipation

Faculty of Medicine, Chulalongkorn University
Chulalongkorn University·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Functional Constipation
Drug/Device/Intervention
Local PEG4000
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Chulalongkorn University
Location
Bangkok, Thailand
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Jun 01, 2026
Enrollment
52 participants
Primary outcome

The frequency of stool,Stool consistency assessed by Bristol stool chart

Summary

This study aims to evaluate the efficacy and palatability of a developed polyethylene
 glycol-based formula compared with the standard polyethylene glycol (PEG) in the treatment of
 children with functional constipation for 8 weeks. Besides, we also aim to assess the side
 effects of a developed PEG-based formula as well as evaluate the change of rectal diameter
 from baseline at each visit between 2 groups.

ICD-10 classifications
ConstipationOther functional intestinal disordersFunctional intestinal disorder, unspecifiedOther specified functional intestinal disordersOther laxatives
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06357897
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06357897 through Pure Global AI's free database. This phase not specified trial is sponsored by Chulalongkorn University and is currently Not yet recruiting. The study focuses on Functional Constipation. Target enrollment is 52 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.